Pharmacy Times Continuing Education logo
CE Activities
Pharmacist Feedback
Poll 4
The patient is prescribed naloxegol and returns one week later with a prescription for ketoconazole. What do you do?
Poll 3
After assessing that your patient was adherent to her bowel regimen, you call her prescriber. The prescriber is interested in targeted therapy for OIC. Which drug do you recommend?
Poll 2
After recommending an over-the-counter bowel regimen, the patient presents three months later with another prescription for oxycodone 5 mg every 6 hours. She complains of uncontrolled pain and troubling constipation associated with her opioid therapy. What do you recommend?
Poll 1
A patient presents a prescription for a 30-day supply of oxycodone 10 mg every 6 hours as needed. How do you proceed?
This activity is supported by educational grants from AstraZeneca LP, Merck Sharp & Dohme, and Novo Nordisk, Inc.

Advancing the Management of Diabetes: An Update on New Guidelines and Treatment Options

Samuel L. Ellis, PharmD, BCPS
Associate Professor
Skaggs School of Pharmacy and
Pharmaceutical Sciences
Aurora, Colorado
The following contributors have no relevant financial relationships with commercial interests to disclose.

Samuel L. Ellis, PharmD, BCPS
Pharmacy Times Office of Continuing Professional Education
Planning Staff—David Heckard; Maryjo Dixon, RPh; Donna Fausak; and Nathalie Harden

Pharmacy Times Editorial Staff
Bea Riemschneider and Kirk McKay
An anonymous peer reviewer was part of the content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Objectives
At the conclusion of this educational activity, participants should be able to:
  • Discuss current management of type 2 diabetes mellitus (T2DM), including updated clinical practice guidelines and the incorporation of new therapeutic classes into practice recommendations.
  • Identify and develop strategies that address clinical inertia and other barriers to optimal management of T2DM.
  • Summarize how the pharmacist’s role is evolving and identify methods to improve diabetes management.
Target Audience: Pharmacists
Type of activity: Knowledge
Release date: May 9, 2014
Expiration date: May 9, 2016
Estimated time to complete activity: 1.5 hours
Fee: Free

Description: Pharmacy Times/Ascend Media Office of Continuing Professional EducationPharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEUs) under the ACPE universal activity number 0290-0000-14-045-H01-P. The activity is available for CE credit through May 9, 2016.

Important Instructions for Obtaining CPE Credit:
To receive a Statement of Credit, participants must complete the pretest, read the article in its entirety and complete the online evaluation and post-test with a score of 70% or better. After successful completion and submission of the online posttest and activity evaluation your credit will be uploaded to CPE Monitor. You may view your credit within 48 hours at

NOTE: All steps must be completed in order to receive credit. Please ensure your Pharmacy Times account is updated with your NABP e-profile number and your date of birth (MMDD format).  Participation data will not be uploaded into CPE MonitorTM if you do not have your NABP e-profile number and date of birth entered into your profile on

Advancing the Management of Diabetes: An Update on New Guidelines and Treatment Options